Top biotech licensing deals of Q1 2023

With mixed market projections regarding overall licensing in 2023, investors will be scrutinizing collaborative efforts more closely this year. Nonetheless, there have already been several big biotech licensing deals in Q1. Below is a sampling of some of this quarter's biggest licensing deals ranging from the surprising and pivotal to the lucrative and consequential.